The global Medical Polymer Splint Market size will grow by US$ 2350 Million by 2028 at a CAGR of 6.1% in the given forecast period.
A splint is a device designed to immobilize an area of the body to allow for healing. Splints are frequently used with soft tissue injuries such as a sprain, overuse injuries like tendonitis, and traumatic injuries such as joint dislocation or complex bone fractures. Fractures such as open, displaced, or those needing surgery where large amount of swelling is expected would be appropriately treated with a splint.
Growing prevalence of musculoskeletal diseases such as arthritis and osteoporosis, which are associated with growing geriatric population, is expected to drive growth of the Medical Polymer Splint market. However, the formation of pressure sores, compartment syndrome, and thermal injuries during splinting process and development of bacterial and fungal infections occurring beneath the splints are factors restraining the market growth.
The global Medical Polymer Splint market is segregated on the basis of Type as Glass fiber, Polyurethane, Resin, and Other. Based on End-User the global Medical Polymer Splint market is segmented in Hospital, Ambulatory Surgical Centers, Clinics, and Others.
The global Medical Polymer Splint market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Medical Polymer Splint market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Performance Health, Anhui Ankang Health Materials, Jiangsu Maibang Biotechnology, AdvaCare Pharma, Jinan Tasite Biotechnology, Glaxsan Pharma, Shaanxi Yuanguang High Technology, Topcare Biotech, Tuoren, Shandong Haidi Ke Biotechnology, and others are among the major players in the global Medical Polymer Splint market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Medical Polymer Splint Market has been segmented as below:
Medical Polymer Splint Market, By Type
Medical Polymer Splint Market, By End-User
Medical Polymer Splint Market, By Region
Medical Polymer Splint Market, By Company
The report covers:
Report Scope:
The global Medical Polymer Splint market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Medical Polymer Splint market share. Major industry players with significant revenue share include Performance Health, Anhui Ankang Health Materials, Jiangsu Maibang Biotechnology, AdvaCare Pharma, Jinan Tasite Biotechnology, Glaxsan Pharma, Shaanxi Yuanguang High Technology, Topcare Biotech, Tuoren, Shandong Haidi Ke Biotechnology, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Pediatric X-Ray Positioning Chair Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Medical Polymer Splint Market, By Type
5.1 Introduction
5.2 Glass fiber
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Polyurethane
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Resin
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Other
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Medical Polymer Splint Market, By End-User
6.1 Introduction
6.2 Hospital
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Ambulatory Surgical Centers
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Clinics
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Others
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Medical Polymer Splint Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Medical Polymer Splint, By Type
7.2.2 North America Medical Polymer Splint, By End-User
7.3 Europe
7.3.1 Europe Medical Polymer Splint, By Type
7.3.2 Europe Medical Polymer Splint, By End-User
7.4 Asia-Pacific
7.4.1 Asia-Pacific Medical Polymer Splint, By Type
7.4.2 Asia-Pacific Medical Polymer Splint, By End-User
7.5 Rest of the World
7.5.1 Rest of the World Medical Polymer Splint, By Type
7.5.2 Rest of the World Medical Polymer Splint, By End-User
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Performance Health
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Anhui Ankang Health Materials
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Jiangsu Maibang Biotechnology
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 AdvaCare Pharma
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Jinan Tasite Biotechnology
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Glaxsan Pharma
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Shaanxi Yuanguang High Technology
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Topcare Biotech
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Tuoren
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Shandong Haidi Ke Biotechnology
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Medical Polymer Splint Market has been segmented as below:
Medical Polymer Splint Market, By Type
Medical Polymer Splint Market, By End-User
Medical Polymer Splint Market, By Region
Medical Polymer Splint Market, By Company
